IMCR

26.4100.83%
JI

John Irving Bell

Independent Non-Executive Chairman

Prof. Sir. John Irving Bell, M.A., DM, FRCP, GBE, FRS, M.D., is Member of Partnership board of Oxford comprehensive Biomedical Research Centre. Prof. Bell is Independent Non-Executive Chairman of Immunocore Holdings plc. Prof. Bell joined the Immunocore Holdings plc on March 30, 2015. Prof. Bell was Director of Immunocore Holdings plc from March 30, 2015. Prof. Bell is Non-Executive Director of Sensyne Health Holdings Limited. Prof. Bell is Senior Advisor of GHO Capital Partners LLP. Prof. Bell is Member of International Advisory Board of Hakluyt & Company Limited from December 2020. Prof. Bell is Member of Scientific Advisory Board of Insitro, Inc. from May 2022. Prof. Bell was Non-Executive Director of Oxford Science Enterprises. Prof. Bell was Non-Executive Director of Roche Holding AG from 2001 to March 18, 2020. Prof. Bell was employed at Roche Holding AG from 2001 to March 18, 2020. Prof. Bell was Director of Genentech, Inc. Prof. Bell was Member of Life Sciences Advisory Board of Advent Venture Partners. Prof. Bell focused on Life Sciences. Prof. Bell was Non-executive Director of Chiron Pharmaceuticals Limited. Prof. Bell was employed at Chiron Pharmaceuticals Limited from September 1993 to April 01, 2017. Prof. Bell was Non-Executive Director of Oxagen Limited until March 2019. Prof. Bell was employed at Oxagen Limited until March 2019. Prof. Bell was Member of Scientific Advisory Board of Protemix Corporation Limited. Prof. Bell was Non-Executive Director of Oxford University Innovation Ltd. Prof. Bell was Chairman of Arcturis Data Limited until October 23, 2018. Prof. Bell was employed at Arcturis Data Limited until October 23, 2018. Prof. Bell is Senior Advisor at Biospring Management, LLC. Prof. Bell was Advisor of Biospring Management, LLC. Prof. Bell has Bachelor's from University of Alberta in 1975, M.B.B.S. from Magdalen College in 1979, B.A. from Magdalen College in 1976, M.D. from Magdalen College in 1990.

Positions